JPH1067620A - Hair grower - Google Patents
Hair growerInfo
- Publication number
- JPH1067620A JPH1067620A JP8241171A JP24117196A JPH1067620A JP H1067620 A JPH1067620 A JP H1067620A JP 8241171 A JP8241171 A JP 8241171A JP 24117196 A JP24117196 A JP 24117196A JP H1067620 A JPH1067620 A JP H1067620A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- oxide
- dimethyl
- paeonia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 73
- 239000000284 extract Substances 0.000 claims abstract description 76
- 150000001412 amines Chemical class 0.000 claims abstract description 34
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 5
- -1 hydroxyethyl group Chemical group 0.000 claims description 31
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 14
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- CCGKOQOJPYTBIH-UHFFFAOYSA-N ethenone Chemical group C=C=O CCGKOQOJPYTBIH-UHFFFAOYSA-N 0.000 claims description 3
- 241000894007 species Species 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 32
- 241000736199 Paeonia Species 0.000 abstract description 15
- 239000000419 plant extract Substances 0.000 abstract description 9
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract description 3
- 244000236658 Paeonia lactiflora Species 0.000 abstract description 3
- 241001474977 Palla Species 0.000 abstract description 3
- 230000003405 preventing effect Effects 0.000 abstract description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract description 2
- 240000005001 Paeonia suffruticosa Species 0.000 abstract description 2
- 241001106477 Paeoniaceae Species 0.000 abstract description 2
- 241000612118 Samolus valerandi Species 0.000 abstract description 2
- 238000005507 spraying Methods 0.000 abstract description 2
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000035617 depilation Effects 0.000 abstract 1
- 230000003450 growing effect Effects 0.000 abstract 1
- LLVMMJCBIODYPV-UHFFFAOYSA-N n,n-bis(hydroxymethyl)dodecan-2-amine oxide Chemical compound CCCCCCCCCCC(C)[N+]([O-])(CO)CO LLVMMJCBIODYPV-UHFFFAOYSA-N 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000003779 hair growth Effects 0.000 description 38
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 201000004384 Alopecia Diseases 0.000 description 19
- 239000000469 ethanolic extract Substances 0.000 description 17
- 230000003676 hair loss Effects 0.000 description 16
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 208000024963 hair loss Diseases 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 229940058015 1,3-butylene glycol Drugs 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 230000003797 telogen phase Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003658 preventing hair loss Effects 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000011550 stock solution Substances 0.000 description 4
- 229930007845 β-thujaplicin Natural products 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000183666 Nepsera aquatica Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000031774 hair cycle Effects 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- WRBUTRDYPBQYLW-UHFFFAOYSA-N 2-decyl-n,n-dimethyltetradecan-1-amine Chemical compound CCCCCCCCCCCCC(CN(C)C)CCCCCCCCCC WRBUTRDYPBQYLW-UHFFFAOYSA-N 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- 240000006891 Artemisia vulgaris Species 0.000 description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- OCIPQWOZACVZPO-UHFFFAOYSA-N n,n-dimethyldecan-2-amine Chemical compound CCCCCCCCC(C)N(C)C OCIPQWOZACVZPO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000020737 peppermint extract Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229940077082 red pepper extract Drugs 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 239000009538 yokuinin Substances 0.000 description 2
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- NIFPWUCDSCRTCA-UHFFFAOYSA-N 2-decyl-n,n-dimethyltetradecan-1-amine oxide Chemical compound CCCCCCCCCCCCC(C[N+](C)(C)[O-])CCCCCCCCCC NIFPWUCDSCRTCA-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- CZBRSCOXSSUUJU-UHFFFAOYSA-N C[N+](C)(C(C)CCCCCCCCCCCCCCCCCC)[O-] Chemical compound C[N+](C)(C(C)CCCCCCCCCCCCCCCCCC)[O-] CZBRSCOXSSUUJU-UHFFFAOYSA-N 0.000 description 1
- WLPQUHNTIDYNCQ-UHFFFAOYSA-N C[N+](C)(C(C)CCCCCCCCCCCCCCCCCCCCCC)[O-] Chemical compound C[N+](C)(C(C)CCCCCCCCCCCCCCCCCCCCCC)[O-] WLPQUHNTIDYNCQ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- TUEKNUUUVBAFLD-UHFFFAOYSA-N N,N-dimethyldecan-2-amine oxide Chemical compound CCCCCCCCC(C)[N+](C)(C)[O-] TUEKNUUUVBAFLD-UHFFFAOYSA-N 0.000 description 1
- BNOFOXJQUYOISZ-UHFFFAOYSA-N N,N-dimethyloctan-2-amine oxide Chemical compound CCCCCCC(C)[N+](C)(C)[O-] BNOFOXJQUYOISZ-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- DNBMHZBEBMYCLV-UHFFFAOYSA-N O[N+](O)(C(C(CCCCCC)CC)CC)[O-] Chemical compound O[N+](O)(C(C(CCCCCC)CC)CC)[O-] DNBMHZBEBMYCLV-UHFFFAOYSA-N 0.000 description 1
- DBIVPFFZHVRZMT-UHFFFAOYSA-N O[N+](O)(C(C(CCCCCCCC)CCCCCCCCCC)CC)[O-] Chemical compound O[N+](O)(C(C(CCCCCCCC)CCCCCCCCCC)CC)[O-] DBIVPFFZHVRZMT-UHFFFAOYSA-N 0.000 description 1
- XJHCGAGRHDEMTK-UHFFFAOYSA-N O[N+](O)(C(CCC)CC)[O-] Chemical compound O[N+](O)(C(CCC)CC)[O-] XJHCGAGRHDEMTK-UHFFFAOYSA-N 0.000 description 1
- TVYXGPWYZVRHEM-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCC)[O-] TVYXGPWYZVRHEM-UHFFFAOYSA-N 0.000 description 1
- DEJSSXGAJHQYQV-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCC)[O-] DEJSSXGAJHQYQV-UHFFFAOYSA-N 0.000 description 1
- YQDDSOQBKBEDON-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCCCC)[O-] YQDDSOQBKBEDON-UHFFFAOYSA-N 0.000 description 1
- BQXNNMPRGAMOBT-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCCCCCC)[O-] BQXNNMPRGAMOBT-UHFFFAOYSA-N 0.000 description 1
- OYSCLHMZVHFKRI-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCCCCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCCCCCCCC)[O-] OYSCLHMZVHFKRI-UHFFFAOYSA-N 0.000 description 1
- HDBAARYTCXSVMH-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCCCCCCCCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCCCCCCCCCCCC)[O-] HDBAARYTCXSVMH-UHFFFAOYSA-N 0.000 description 1
- ZELQDOYFBUTQTJ-UHFFFAOYSA-N O[N+](O)(C(CCC)CCCCCCCCCCCCCCCCCC)[O-] Chemical compound O[N+](O)(C(CCC)CCCCCCCCCCCCCCCCCC)[O-] ZELQDOYFBUTQTJ-UHFFFAOYSA-N 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 240000005893 Pteridium aquilinum Species 0.000 description 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 239000010315 Tanjin extract Substances 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LUTSRLYCMSCGCS-BWOMAWGNSA-N [(3s,8r,9s,10r,13s)-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,16-decahydrocyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(=O)CC=C3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 LUTSRLYCMSCGCS-BWOMAWGNSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 206010068168 androgenetic alopecia Diseases 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229940107588 barberry extract Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- JFIOVJDNOJYLKP-UHFFFAOYSA-N bithionol Chemical compound OC1=C(Cl)C=C(Cl)C=C1SC1=CC(Cl)=CC(Cl)=C1O JFIOVJDNOJYLKP-UHFFFAOYSA-N 0.000 description 1
- 229960002326 bithionol Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000001599 crocus sativus l. flower extract Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000003915 liquefied petroleum gas Substances 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- NRKNFPVBYDDFCG-UHFFFAOYSA-N n,n-dihydroxybutan-1-amine oxide Chemical compound CCCC[N+](O)(O)[O-] NRKNFPVBYDDFCG-UHFFFAOYSA-N 0.000 description 1
- GVCJLBCBROVYIE-UHFFFAOYSA-N n,n-dihydroxyoctadecan-4-amine oxide Chemical compound CCCCCCCCCCCCCCC([N+](O)(O)[O-])CCC GVCJLBCBROVYIE-UHFFFAOYSA-N 0.000 description 1
- CZHITHHCSDBMNR-UHFFFAOYSA-N n,n-dimethylbutan-2-amine oxide Chemical compound CCC(C)[N+](C)(C)[O-] CZHITHHCSDBMNR-UHFFFAOYSA-N 0.000 description 1
- WWTZPQPNQQUDTA-UHFFFAOYSA-N n,n-dimethyldodecan-2-amine oxide Chemical compound CCCCCCCCCCC(C)[N+](C)(C)[O-] WWTZPQPNQQUDTA-UHFFFAOYSA-N 0.000 description 1
- MECBYDXMJQGFGQ-UHFFFAOYSA-N n,n-dimethylethanamine oxide Chemical compound CC[N+](C)(C)[O-] MECBYDXMJQGFGQ-UHFFFAOYSA-N 0.000 description 1
- YTMRCGDXXPVCNT-UHFFFAOYSA-N n,n-dimethylhexadecan-2-amine oxide Chemical compound CCCCCCCCCCCCCCC(C)[N+](C)(C)[O-] YTMRCGDXXPVCNT-UHFFFAOYSA-N 0.000 description 1
- QMQRPFWKJWNKCJ-UHFFFAOYSA-N n,n-dimethylhexan-2-amine Chemical compound CCCCC(C)N(C)C QMQRPFWKJWNKCJ-UHFFFAOYSA-N 0.000 description 1
- HSBSOVIYJBFRST-UHFFFAOYSA-N n,n-dimethylhexan-2-amine oxide Chemical compound CCCCC(C)[N+](C)(C)[O-] HSBSOVIYJBFRST-UHFFFAOYSA-N 0.000 description 1
- GHKNNRITBAAVJP-UHFFFAOYSA-N n,n-dimethyloctadecan-2-amine oxide Chemical compound CCCCCCCCCCCCCCCCC(C)[N+](C)(C)[O-] GHKNNRITBAAVJP-UHFFFAOYSA-N 0.000 description 1
- KOMQGNYXBSXJTG-UHFFFAOYSA-N n,n-dimethyltetradecan-2-amine Chemical compound CCCCCCCCCCCCC(C)N(C)C KOMQGNYXBSXJTG-UHFFFAOYSA-N 0.000 description 1
- MCCDQLDGOIFDGF-UHFFFAOYSA-N n,n-dimethyltetradecan-2-amine oxide Chemical compound CCCCCCCCCCCCC(C)[N+](C)(C)[O-] MCCDQLDGOIFDGF-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 229940076591 saffron extract Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940048730 senega Drugs 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000004037 social stress Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- PMBRBOODEWULOI-UHFFFAOYSA-N trichloromethanide Chemical compound Cl[C-](Cl)Cl PMBRBOODEWULOI-UHFFFAOYSA-N 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、養毛料に関する技
術分野に属する。より詳細には、優れた脱毛防止効果や
発毛効果等の養毛効果を有する養毛料に関する技術分野
に属し、本発明養毛料は、特に医薬品,医薬部外品又は
化粧品の分野において用いられる。TECHNICAL FIELD The present invention belongs to the technical field related to hair restoration. More specifically, it belongs to the technical field related to a hair restorer having an excellent hair loss-preventing effect and a hair-growth effect such as a hair-growth effect, and the hair restorer of the present invention is used particularly in the fields of pharmaceuticals, quasi-drugs, and cosmetics.
【0002】[0002]
【従来の技術】養毛料は、頭髪の成長を促進又は刺激す
る製品であり、高齢化社会を迎えた今日では、社会的な
ストレスの増大も伴い、年々その需要は増大しつつあ
る。一般的に、頭部の禿や脱毛の原因としては、毛根や
皮脂腺等の器官における男性ホルモンの活性化、毛包へ
の血流量の低下、皮脂の分泌過剰、過酸化物の生成によ
る頭皮の異常、栄養不良、ストレス等多様な原因が考え
られている。従来の養毛料は、一般的にこれらの禿や脱
毛の原因と考えられる要素を取り除いたり、軽減する作
用を持つ物質を配合したものである。例えば、ビタミン
B,ビタミンE等のビタミン類、セリン,メチオニン等
のアミノ酸類、センブリエキス,アセチルコリン誘導体
等の血管拡張剤、紫根エキス,ヒノキチオール等の抗炎
症剤、エストラジオール等の女性ホルモン剤、セファラ
ンチン等の皮膚機能亢進剤等が配合され、禿や脱毛の予
防及び治療に用いられている。2. Description of the Related Art Hair restoration is a product that promotes or stimulates the growth of hair, and in today's aging society, the demand for hair growth is increasing year by year as social stress increases. In general, the causes of head baldness and hair loss include the activation of androgens in organs such as hair roots and sebaceous glands, decreased blood flow to hair follicles, excessive secretion of sebum, and the production of peroxides in the scalp. Various causes such as abnormalities, malnutrition, and stress are considered. Conventional hair restorations generally contain a substance having an action of removing or reducing factors considered to be the cause of baldness and hair loss. For example, vitamins such as vitamin B and vitamin E, amino acids such as serine and methionine, vasodilators such as assembly extract and acetylcholine derivatives, anti-inflammatory agents such as purple root extract and hinokitiol, female hormones such as estradiol, cepharanthin and the like Are used in the prevention and treatment of baldness and hair loss.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、前記の
ように多くの試みがなされているにもかかわらず、従来
の養毛剤の脱毛防止効果や発毛効果等の養毛効果が必ず
しも十分なものではなかった。この理由として、前記の
通り禿や脱毛の原因が非常に多様であり、発毛の機構自
体も非常に複雑であるため、それらの原因や機構の一面
のみに着目した養毛料では十分ではないということが挙
げられる。However, in spite of many attempts as described above, the hair-growing effects such as the hair-growth-preventing effect and the hair-growth effect of the conventional hair-growing agent are not always sufficient. Was. The reason for this is that, as described above, the causes of baldness and hair loss are extremely diverse, and the mechanism of hair growth itself is also very complicated, so it is not enough to use a hair restoration that focuses only on those causes and one aspect of the mechanism. It is mentioned.
【0004】[0004]
【課題を解決するための手段】本発明者は、この課題の
解決に向けて、優れた脱毛防止効果や発毛効果を有する
新たな養毛料を提供することに向けて鋭意検討を行っ
た。その結果、特定の植物抽出物と特定のアミンオキシ
ドを組み合わせて配合した養毛料が優れた養毛効果を有
することを見出し本発明を完成した。Means for Solving the Problems In order to solve this problem, the present inventor has made intensive studies to provide a new hair restorer having an excellent hair loss preventing effect and a hair growth effect. As a result, the present inventors have found that a hair restorer prepared by combining a specific plant extract and a specific amine oxide has an excellent hair restorer effect, and completed the present invention.
【0005】すなわち本発明は、以下の成分及びを
含んでなる養毛料を提供する。 シャクヤク抽出物及び/又はボタンピ抽出物 下記式(I)で表されるアミンオキシドの1種又は2
種以上:That is, the present invention provides a hair restorer comprising the following components: Peony extract and / or peanut extract One or two amine oxides represented by the following formula (I)
More than species:
【化2】 (式中、R1 は炭素数が2〜24の直鎖の又は分枝鎖の
アルキル基、R2 は、メチル基又はヒドロキシエチル
基、Aはモノオキシエチレン基、nは0以上5以下の数
を表す)。Embedded image (Wherein, R 1 is a linear or branched alkyl group having 2 to 24 carbon atoms, R 2 is a methyl group or a hydroxyethyl group, A is a monooxyethylene group, and n is 0 or more and 5 or less. Represents a number).
【0006】[0006]
【発明の実施の形態】以下、本発明の実施の形態につい
て説明する。 A.本発明養毛料は、シャクヤク抽出物及び/又はボタ
ンピ抽出物を含んでなる。Embodiments of the present invention will be described below. A. The hair restorer of the present invention comprises a peony extract and / or a peanut extract.
【0007】本発明に配合するシャクヤク抽出物は、ボ
タン科シャクヤク〔Paeonia lactiflora Pallas(Paeoni
a albiflora Pallas var. trichocarpa Bunge)〕及びこ
の近縁植物の根の抽出物である。また、ボタンピ抽出物
は同じくボタン科ボタン〔Paeonia suffruticosa Andre
ws(Paeonia mountan Sims)(Paeoniaceae )〕及びこ
の近縁植物の根皮の抽出物である。これらの抽出物の上
記の原料からの抽出方法としては、通常公知の方法を用
いることができる。例えば、上記の原料を熱水、メタノ
ール,エタノール等の低級アルコール若しくはこれらの
低級アルコールの含水物又はプロピレングリコール、
1,3−ブチレングリコール等の多価アルコール若しく
はこれらの多価アルコールの含水物等の溶媒で溶媒抽出
することにより得ることが可能である。これらの植物抽
出物は、それぞれ単独で本発明養毛料中に配合すること
も可能であるが、両者を組み合わせて配合することも可
能である。[0007] The peony extract used in the present invention is a peony [Paeonia lactiflora Pallas (Paeoni)
trichocarpa Bunge)] and the root extract of this closely related plant. In addition, the peanut extract is also a button family button [Paeonia suffruticosa Andre
ws (Paeonia mountan Sims) (Paeoniaceae)] and the root bark extract of this closely related plant. As a method for extracting these extracts from the above-mentioned raw materials, generally known methods can be used. For example, the above-mentioned raw materials are prepared from hot water, lower alcohols such as methanol and ethanol or hydrates of these lower alcohols or propylene glycol;
It can be obtained by solvent extraction with a solvent such as a polyhydric alcohol such as 1,3-butylene glycol or a hydrate of these polyhydric alcohols. Each of these plant extracts can be independently incorporated into the hair restoration of the present invention, or both can be incorporated in combination.
【0008】また、これらの植物抽出物の本発明養毛料
中における配合量は、具体的に配合する植物抽出物の組
み合わせや本発明養毛料の具体的な態様に応じて適宜変
更されるべきもので特に限定されるべきものではない
が、概ね養毛料全量中、植物抽出物の乾燥重量として、
0.005重量%以上,同20重量%以下が好ましく、
特に好ましくは、同0.01重量%以上,同5重量%以
下である。配合量が上記0.005重量%未満であると
本発明の所期の効果が十分に発揮されない傾向があり好
ましくなく、20重量%を越えて配合すると製剤上支障
をきたすことが多くなり好ましくない。The amount of these plant extracts in the hair growth composition of the present invention should be appropriately changed according to the specific combination of the plant extract to be blended and the specific mode of the hair growth composition of the present invention. Although not to be limited, in general, in the total amount of hair restoration, as the dry weight of the plant extract,
0.005% by weight or more and 20% by weight or less are preferable,
Particularly preferably, the content is 0.01% by weight or more and 5% by weight or less. If the amount is less than the above 0.005% by weight, the intended effect of the present invention tends not to be sufficiently exerted, which is not preferable. If the amount exceeds 20% by weight, it often causes troubles in the preparation, which is not preferable. .
【0009】B.本発明養毛料は、式(I)で表される
アミンオキシドを含んでなる。このアミンオキシド
(I)は、大別して3つの態様に分けることができる。
すなわち、アミンオキシド(I)のR2 がメチル基であ
り、n=0であるジメチルアルキルアミンオキシド
(a);同じくR2 がヒドロキシエチル基であり、n=
0であるジヒドロキシエチルアルキルアミンオキシド
(b)又は同じくR2がメチル基であり、n>1である
ジメチルアルキルポリオキシエチレンアミンオキシド
(c)に大別することができる。B. The hair restorer of the present invention comprises an amine oxide represented by the formula (I). The amine oxide (I) can be roughly classified into three modes.
That is, dimethylalkylamine oxide (a) in which R 2 of amine oxide (I) is a methyl group and n = 0; similarly, R 2 is a hydroxyethyl group;
Dihydroxyethylalkylamine oxide (b), which is 0, or dimethylalkylpolyoxyethyleneamine oxide (c), wherein R 2 is a methyl group and n> 1.
【0010】また、炭素数が2〜24の直鎖アルキル基
又は分枝鎖アルキル基であるR1 としては、エチル基,
プロピル基,ブチル基,ペンチル基,ヘキシル基,ヘプ
チル基,オクチル基,ノニル基,デシル基,ウンデシル
基,ドデシル基,トリデシル基,テトラデシル基,ペン
タデシル基,ヘキサデシル基,ヘプタデシル基,オクタ
デシル基,ノナデシル基,エイコサシル基,ヘンエイコ
サシル基,ドコサシル基,トリコサニル基又はテトラコ
サニル基等の直鎖アルキル基;イソプロピル基,イソブ
チル基,sec-ブチル基,tert-ブチル基,イソペンチル
基,ネオペンチル基,tert-ペンチル基,イソヘキシル
基等の分枝鎖アルキル基等を例示することができる。R 1 which is a straight-chain alkyl group or a branched-chain alkyl group having 2 to 24 carbon atoms is an ethyl group,
Propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl , Eicosacyl, heneicosacyl, docosacyl, tricosanyl or tetracosanyl; linear alkyl groups; isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl, tert-pentyl, isohexyl Examples include a branched alkyl group such as a group.
【0011】また、モノオキシエチレン基Aの重合数で
あるnは、アミンオキシド(I)がジメチルアルキルポ
リオキシエチレンアミンオキシドである場合には、1以
上5以下の範囲である。The polymerization number n of the monooxyethylene group A is in the range of 1 to 5 when the amine oxide (I) is dimethylalkylpolyoxyethylene amine oxide.
【0012】具体的に、ジメチルアルキルアミンオキシ
ド(a)としては、N,N−ジメチル−2−エチルアミ
ンオキシド、N,N−ジメチル−2−ブチルアミンオキ
シド、N,N−ジメチル−2−ヘキシルアミンオキシ
ド、N,N−ジメチル−2−オクチルアミンオキシド、
N,N−ジメチル−2−デシルアミンオキシド、N,N
−ジメチル−2−ドデシルアミンオキシド、N,N−ジ
メチル−2−テトラデシルアミンオキシド、N,N−ジ
メチル−2−ヘキサデシルアミンオキシド、N,N−ジ
メチル−2−オクタデシルアミンオキシド、N,N−ジ
メチル−2−エイコシルアミンオキシド、N,N−ジメ
チル−2−テトラエイコシルアミンオキシド、N,N−
ジメチル−2−デシルテトラデシルアミンオキシド等を
例示することができる。Specifically, dimethylalkylamine oxide (a) includes N, N-dimethyl-2-ethylamine oxide, N, N-dimethyl-2-butylamine oxide, N, N-dimethyl-2-hexylamine oxide , N, N-dimethyl-2-octylamine oxide,
N, N-dimethyl-2-decylamine oxide, N, N
-Dimethyl-2-dodecylamine oxide, N, N-dimethyl-2-tetradecylamine oxide, N, N-dimethyl-2-hexadecylamine oxide, N, N-dimethyl-2-octadecylamine oxide, N, N -Dimethyl-2-eicosylamine oxide, N, N-dimethyl-2-tetraeicosylamine oxide, N, N-
Dimethyl-2-decyltetradecylamine oxide and the like can be exemplified.
【0013】また、ジヒドロキシエチルアルキルアミン
オキシド(b)としては、N,N−ジヒドロキシエチル
−2−エチルアミンオキシド、N,N−ジヒドロキシエ
チル−2−ブチルアミンオキシド、N,N−ジヒドロキ
シエチル−2−ヘキシルアミンオキシド、N,N−ジヒ
ドロキシエチル−2−ヘキシルアミンオキシド、N,N
−ジヒドロキシエチル−2−オクチルアミンオキシド、
N,N−ジヒドロキシエチル−2−エチルオクチルアミ
ンオキシド、N,N−ジヒドロキシエチル−2−デシル
アミンオキシド、N,N−ジヒドロキシエチル−2−ド
デシルアミンオキシド、N,N−ジヒドロキシエチル−
2−テトラデシルアミンオキシド、N,N−ジヒドロキ
シエチル−2−ヘキサデシルアミンオキシド、N,N−
ジヒドロキシエチル−2−オクタデシルアミンオキシ
ド、N,N−ジヒドロキシエチル−2−エイコシルアミ
ンオキシド、N,N−ジヒドロキシエチル−2−デシル
デシルアミンオキシド、N,N−ジヒドロキシエチル−
2−デシルデシルアミンテトラエイコシルアミンオキシ
ド等を例示することができる。The dihydroxyethylalkylamine oxide (b) includes N, N-dihydroxyethyl-2-ethylamine oxide, N, N-dihydroxyethyl-2-butylamine oxide, N, N-dihydroxyethyl-2-hexyl. Amine oxide, N, N-dihydroxyethyl-2-hexylamine oxide, N, N
-Dihydroxyethyl-2-octylamine oxide,
N, N-dihydroxyethyl-2-ethyloctylamine oxide, N, N-dihydroxyethyl-2-decylamine oxide, N, N-dihydroxyethyl-2-dodecylamine oxide, N, N-dihydroxyethyl-
2-tetradecylamine oxide, N, N-dihydroxyethyl-2-hexadecylamine oxide, N, N-
Dihydroxyethyl-2-octadecylamine oxide, N, N-dihydroxyethyl-2-eicosylamine oxide, N, N-dihydroxyethyl-2-decyldecylamine oxide, N, N-dihydroxyethyl-
Examples include 2-decyldecylamine tetraeicosylamine oxide.
【0014】また、ジメチルアルキルポリオキシエチレ
ンアミンオキシド(c)としては、ジメチルエチルポリ
オキシエチレン(1.5モル)アミンオキシド、ジメチ
ルブチルポリオキシエチレン(3モル)アミンオキシ
ド、ジメチルヘキシルポリオキシエチレン(5モル)ア
ミンオキシド、ジメチルオクチルポリオキシエチレン
(3モル)アミンオキシド、ジメチルデシルポリオキシ
エチレン(1.5モル)アミンオキシド、ジメチルドデ
シルポリオキシエチレン(3モル)アミンオキシド、ジ
メチルテトラデシルポリオキシエチレン(5モル)アミ
ンオキシド、ジメチルヘキサデシルポリオキシエチレン
(3モル)アミンオキシド、ジメチルオクタデシルポリ
オキシエチレン(1.5モル)アミンオキシド、ジメチ
ルエエイコシルポリオキシエチレン(1.5モル)アミ
ンオキシド、ジメチルテトラエエイコシルポリオキシエ
チレン(1.5モル)アミンオキシド等を例示すること
ができる。The dimethylalkyl polyoxyethylene amine oxide (c) includes dimethylethyl polyoxyethylene (1.5 mol) amine oxide, dimethylbutyl polyoxyethylene (3 mol) amine oxide, dimethylhexyl polyoxyethylene (c). 5 mol) amine oxide, dimethyl octyl polyoxyethylene (3 mol) amine oxide, dimethyl decyl polyoxy ethylene (1.5 mol) amine oxide, dimethyl dodecyl polyoxy ethylene (3 mol) amine oxide, dimethyl tetradecyl polyoxy ethylene (5 mol) amine oxide, dimethyl hexadecyl polyoxyethylene (3 mol) amine oxide, dimethyl octadecyl polyoxyethylene (1.5 mol) amine oxide, dimethyl eicosyl polio Shiechiren (1.5 mol) amine oxide, dimethyl tetra et eicosyl polyoxyethylene (1.5 moles) amine oxide can be exemplified.
【0015】これらのアミンオキシド(I)は、単独で
本発明養毛料中に配合することも可能であるが、複数の
アミンオキシド(I)を組み合わせて配合することも可
能である。These amine oxides (I) can be used alone in the hair restorer of the present invention, but can also be used in combination with a plurality of amine oxides (I).
【0016】また、これらのアミンオキシド(I)の本
発明養毛料中における配合量は、具体的に配合するアミ
ンオキシド(I)の組み合わせや本発明養毛料の具体的
な態様に応じて適宜変更されるべきもので特に限定され
るべきものではないが、概ね養毛料全量中0.0001
重量%以上、同20重量%以下が好ましく、同0.01
重量%以上、同5重量%以下が特に好ましい。配合量が
養毛料全量中0.0001重量%未満であると本発明の
所期の効果が十分に発揮されない傾向があり好ましくな
く、20重量%を越えて配合しても配合量の増加に見合
った効果の増強が見られず好ましくない。このようにし
て、上記植物抽出物とアミンオキシド(I)を組み合わ
せて配合することにより、極めて優れた脱毛防止効果や
発毛効果を有する養毛料が提供される。The amount of the amine oxide (I) in the hair growth composition of the present invention may be appropriately changed according to the specific combination of the amine oxide (I) and the specific mode of the hair growth composition of the invention. Although it is not particularly limited in what is to be performed, generally 0.0001 in the total amount of the hair restoration
% By weight and 20% by weight or less, preferably 0.01% by weight or less.
It is particularly preferably at least 5% by weight and not more than 5% by weight. If the amount is less than 0.0001% by weight based on the total amount of the hair restorer, the intended effect of the present invention tends not to be sufficiently exerted, which is not preferable. Even if the amount exceeds 20% by weight, the amount increases. This is not preferable because no enhanced effect is observed. Thus, by combining the above-mentioned plant extract and the amine oxide (I) in combination, a hair restorer having an extremely excellent hair loss preventing effect and a hair growth effect is provided.
【0017】なお、本発明養毛料中には、通常養毛料中
に配合される養毛成分をその養毛成分が有する一般的な
効果を発揮させる目的のために、本発明の所期の効果を
損なわない限りにおいて配合することも可能である。例
えば、アルコキシカルボニルピリジンN−オキシドの
他、塩化カプロニウム、センブリエキス、アセチルコリ
ン誘導体等の血管拡張剤;セリン,メチオニン等のアミ
ノ酸類;ビタミンB6 ,ビタミンE又はその誘導体,ビ
オチン等のビタミン類;パントテン酸又はその誘導体;
グリチルレチン酸又はその誘導体;ニコチン酸ベンジル
等のニコチン酸エステル類;セファランチン等の皮膚機
能亢進剤、エストラジオール等の女性ホルモン剤等を本
発明養毛料中に配合することもできる。In the hair restoration of the present invention, the desired effect of the present invention is intended for the purpose of exhibiting the general effect of the hair restoration component normally incorporated in the hair restoration. Can be blended as long as is not impaired. For example, other alkoxycarbonyl pyridine N- oxide, Kapuroniumu chloride, assembly extract, vasodilators such as acetylcholine derivatives; serine, amino acids such as methionine, vitamin B 6, vitamin E or a derivative thereof, vitamins such as biotin; pantothenic An acid or a derivative thereof;
Glycyrrhetinic acid or a derivative thereof; nicotinic acid esters such as benzyl nicotinate; skin function enhancers such as cepharanthin; and female hormones such as estradiol can also be incorporated in the hair restorer of the present invention.
【0018】また、通常養毛料中に配合される植物抽出
物、例えばアルテア抽出物,ヨクイニン抽出物,ペパー
ミント抽出物,ヨウテイ抽出物,トウガラシ抽出物,ア
ロエ抽出物,クコ抽出物,ヨモギ抽出物,イネ抽出物,
マンケイシ抽出物,マンネンロウ抽出物,コッサイホ抽
出物,エニシダ抽出物,リンドウ抽出物,タンジン抽出
物,ヘチマ抽出物,キキョウ抽出物,マツ抽出物,クジ
ン抽出物,トウキ抽出物,ベニバナ抽出物,メギ抽出
物,ビンロウジ抽出物,ユーカリ抽出物,カゴソウ抽出
物,モクツウ抽出物,ゴシツ抽出物,サイコ抽出物,チ
ャ抽出物,カンゾウ抽出物,ホップ抽出物,キク抽出
物,セネガ抽出物,ゴマ抽出物,センキュウ抽出物,カ
シュウ抽出物,クコ抽出物,ヨモギ抽出物,カッコン抽
出物,マイカイカ抽出物,サフラン抽出物,ローズマリ
ー抽出物,ジオウ抽出物,ゼニアオイ抽出物等を本発明
養毛料中に配合することができる。[0018] Also, plant extracts usually blended in hair restorations, such as Altea extract, yokuinin extract, peppermint extract, ginkgo extract, capsicum extract, aloe extract, wolfberry extract, mugwort extract, Rice extract,
Mankeishi extract, Mannen wax extract, Kosaiho extract, Enishida extract, Gentian extract, Tanjin extract, Loofah extract, Kikyo extract, Pine extract, Kuddin extract, Touki extract, safflower extract, Barberry extract Material, betel nut extract, eucalyptus extract, sprouts extract, mokutsu extract, gossip extract, psycho extract, tea extract, licorice extract, hop extract, chrysanthemum extract, senega extract, sesame extract, A hair extract of the present invention is blended with an extract of Sengoku, an extract of cashew, an extract of wolfberry, an extract of mugwort, an extract of cuckoo, an extract of maikai, an extract of saffron, an extract of rosemary, an extract of magnolia, a mallow extract, etc. be able to.
【0019】また、ヒノキチオール.ヘキサクロロフェ
ン.ベンザルコニウムクロリド,セチルピリジニウムク
ロリド,ウンデシレン酸,トリクロロカルバニド、ビチ
オノール等の抗菌剤;メントール等の清涼剤;サリチル
酸,亜鉛又はその誘導体;乳酸又はそのアルキルエステ
ル等の薬剤;クエン酸等の有機酸類;トラネキサム酸等
のプロテアーゼ阻害剤;アルギニン等のアミノ酸類;オ
リーブ油,スクワラン,流動パラフィン,イソプロピル
ミリステート,高級脂肪酸,高級アルコール等の油分;
グリセリン,プロピレングリコール等の多価アルコー
ル、その他界面活性剤、保湿剤、増粘剤、香料、酸化防
止剤、紫外線吸収剤、色素、エタノール、水等を本発明
の所期の効果を損なわない範囲で適宜配合することがで
きる。Also, hinokitiol. Hexachlorophen. Antibacterial agents such as benzalkonium chloride, cetylpyridinium chloride, undecylenic acid, trichlorocarbanide and bitionol; cooling agents such as menthol; salicylic acid, zinc or derivatives thereof; drugs such as lactic acid or its alkyl ester; organic acids such as citric acid Protease inhibitors such as tranexamic acid; amino acids such as arginine; oils such as olive oil, squalane, liquid paraffin, isopropyl myristate, higher fatty acids and higher alcohols;
Polyhydric alcohols such as glycerin and propylene glycol, other surfactants, humectants, thickeners, fragrances, antioxidants, ultraviolet absorbers, dyes, ethanol, water, etc., do not impair the intended effects of the present invention. Can be appropriately blended.
【0020】本発明養毛料の形態は、液状,乳液,軟膏
等外皮に適用可能な性状のものであれば問われるもので
はなく、必要に応じて適宜基剤成分等を配合して所望の
形態の本発明養毛料を調製することができる。また、本
発明養毛料は、医薬品,医薬部外品又は化粧品等の多様
な分野において適用可能である。The form of the hair restorer of the present invention is not particularly limited as long as it can be applied to the outer skin such as a liquid, an emulsion, an ointment, and the like. Of the present invention can be prepared. In addition, the hair restoration of the present invention can be applied in various fields such as pharmaceuticals, quasi-drugs, and cosmetics.
【0021】本発明養毛料は、脱毛の治療や予防に用い
ることが可能であり、例えば男性性脱毛症の治療や予
防、女性に多いびまん性脱毛症の治療や予防、円形脱毛
症の治療等に広く用いることができる。なお、ここに示
した脱毛疾患名は例示であり、これらの脱毛疾患に本発
明養毛料の適用可能な疾患が限定されるものではない。The hair restorer of the present invention can be used for the treatment and prevention of alopecia, for example, the treatment and prevention of androgenetic alopecia, the treatment and prevention of diffuse alopecia common to women, the treatment of alopecia areata, etc. Can be widely used. It should be noted that the names of hair loss diseases shown here are examples, and diseases to which the hair restoration of the present invention can be applied are not limited to these hair loss diseases.
【0022】本発明養毛料は、概ね皮膚に直接塗布又は
散布する等の経皮投与で投与される。そして、本発明養
毛料の投与量は、年齢,脱毛の程度等の個人差に応じて
適宜決定されるべきものであるが、一般の大人に対する
投与量は、体重1Kg当り0.01〜100mg/日、好ま
しくは0.1〜10mg/日であり、これを1日1回又は
2〜4回に分けて投与することができる。The hair restorer of the present invention is generally administered by transdermal administration such as directly applying or spraying on the skin. The dose of the hair restorer of the present invention should be appropriately determined according to individual differences such as age and degree of hair loss, but the dose for general adults is 0.01 to 100 mg / kg body weight. Daily, preferably 0.1 to 10 mg / day, which can be administered once a day or divided into 2 to 4 times a day.
【0023】[0023]
【実施例】以下、実施例等により本発明をより具体的に
説明するが、これらの実施例等により本発明の技術的範
囲が限定されるべきものではない。まず、各実施例の開
示に先立ち、これらの実施例等の養毛効果を検討するた
めの試験について説明する。EXAMPLES Hereinafter, the present invention will be described more specifically with reference to Examples and the like, but the technical scope of the present invention should not be limited by these Examples and the like. First, prior to the disclosure of each embodiment, tests for examining the hair-growing effect of these embodiments and the like will be described.
【0024】1.発毛試験 毛周期の休止期にあるC3H/HeNCrJマウスを用
い、小川らの方法(ノーマル アンド アブノーマル
エピダーマル ディファレンシェーション(Normal and
Abnormal Epidermal Differentiation ,M.Seiji 及び
I.A.Bernstein編集、第159 〜170 頁,1982年,東大出
版)により発毛試験を行う。すなわち、マウスを1群1
0匹とし、無塗布,実施例及び比較例の各群に分け、バ
リカン及びシェーバーでマウスの背部を剃毛し、それぞ
れのサンプルを1日1回、0.1mlずつ塗布する。各サ
ンプルの発毛効果は、マウス背部の発毛部分の面積比
(発毛部分の面積/剃毛部分の面積×100=発毛率)
によって評価する。1. Hair growth test Using C3H / HeNCrJ mice in the telogen phase of the hair cycle, the method of Ogawa et al. (Normal and Abnormal)
Epidermal Differentiation (Normal and
Abnormal Epidermal Differentiation, M. Seiji and
A hair growth test is performed according to IABernstein, pp. 159-170, 1982, published by The University of Tokyo. That is, mice are group 1
The number of mice was zero, and the mice were uncoated, divided into groups of Examples and Comparative Examples. The backs of the mice were shaved with a hair clipper and a shaver, and 0.1 ml of each sample was applied once a day. The hair growth effect of each sample was calculated as the area ratio of the hair growth part on the back of the mouse (the area of the hair growth part / the area of the shaved part × 100 = hair growth rate).
Assess by
【0025】2.養毛効果試験 本発明養毛料の脱毛防止効果、発毛効果等の養毛作用に
ついてさらに検討するために、健常人に対してトリコグ
ラム試験及び脱毛防止試験を行う。 トリコグラム試験 養毛料の使用前と使用後の抜去毛髪を顕微鏡で観察し、
毛根の形態から休止期の毛根数を計数し(休止期の毛根
は、成長の止まった毛の毛根であり、脱毛を訴える人は
正常な人よりも、この休止期の毛根の割合が多いことが
認められている。)、その割合の増減によって養毛料の
養毛作用を比較する。具体的には、本発明養毛料を男性
被験者10名の頭皮に1日2回、1回当り5mlずつ6ヵ
月連続して塗布し、塗布直前及び6ヵ月間塗布終了直前
に被験者1名に付き100本ずつ抜去し、それぞれの毛
根を上記のように検討する。2. Hair Restoration Effect Test In order to further examine the hair restoration effect such as the hair loss prevention effect and the hair growth effect of the hair restorer of the present invention, a tricogram test and a hair loss prevention test are performed on healthy individuals. Tricogram test The hair removed before and after use of the hair restoration was observed under a microscope,
Count the number of telogen follicles from the morphology of the follicles (the telogen follicles are the roots of hair that has stopped growing, and those who report hair loss have a higher percentage of this telogen follicle than normal people. Is observed.), And the hair growth effect of the hair growth material is compared by increasing or decreasing the ratio. Specifically, the hair restorer of the present invention was applied to the scalp of 10 male subjects twice a day, 5 ml per time, for 6 consecutive months, and applied to one subject immediately before application and immediately before the end of application for 6 months. One hundred hairs are withdrawn and each hair root is examined as described above.
【0026】脱毛防止試験 養毛料の使用前と使用後の洗髪時の脱毛本数の変化を養
毛料の脱毛防止効果の指標とした。すなわち、上記トリ
コグラム試験の開始2ヵ月前を試料無塗布期間とし、こ
の試験開始前1週間と開始後6ヵ目に被験者に毎日洗髪
させ、その際の抜毛を回収させ、太さが50um以上の毛
髪の本数を数えた。そして、被験者毎に1日平均抜毛本
数の変化率(養毛料塗布期間の平均抜毛本数/無塗布期
間の平均抜毛本数×100)を求めた。Hair Loss Prevention Test The change in the number of hair loss before and after use of the hair restorer during hair washing was used as an index of the hair loss preventive effect of the hair restorer. That is, two months before the start of the tricogram test was defined as a sample non-application period, and the subject was washed every day one week before the start of the test and six days after the start, and the hair removed at that time was collected, and the thickness was 50 μm or more. The number of hair was counted. Then, the change rate of the average number of hair removals per day for each subject (the average number of hair removals during the hair application period / the average number of hair removals during the no application period × 100) was determined.
【0027】〔実施例1〜19〕第1表(第1表−1,
2,3)に示す処方で養毛料を調製した。[Examples 1 to 19] Table 1 (Table 1-1)
A hair restorer was prepared according to the formulation shown in 2, 3).
【表1】 [Table 1]
【0028】[0028]
【表2】 [Table 2]
【0029】[0029]
【表3】 [Table 3]
【0030】<製造法>95%エタノールに、アミンオ
キシド(I)、硬化ヒマシ油エチレンオキシド(40モ
ル)付加物並びにシャクヤク抽出物及び/又はボタンピ
抽出物を添加し、攪拌して溶解し、次いでイオン交換水
を添加して混合して所望する養毛料を調製した。<Production method> To 95% ethanol, an amine oxide (I), an adduct of hydrogenated castor oil and ethylene oxide (40 mol), and a peony extract and / or a red pepper extract were added, and dissolved by stirring. Exchanged water was added and mixed to prepare a desired hair restorer.
【0031】上記第1表に示した実施例の養毛料の上記
発毛試験の結果を、比較例についての結果と共に第2表
に表す。The results of the hair growth test of the hair growth preparations of the examples shown in Table 1 are shown in Table 2 together with the results of the comparative examples.
【表4】 [Table 4]
【0032】このように、アミンオキシド(I)並びに
特定の植物抽出成分であるシャクヤク抽出物及び/又は
ボタンピ抽出物を配合した本発明養毛料は、これらの成
分のうち一方のみを配合した比較例の養毛料に比べて、
毛髪サイクルを休止期から成長期に移行させる発毛効果
に優れていることが判明した。As described above, the hair restorer of the present invention containing the amine oxide (I) and the peony extract and / or the peanut extract which is a specific plant extract is a comparative example containing only one of these components. Compared to the hair nourishing
It was found that the hair growth effect of shifting the hair cycle from the telogen to the anagen was excellent.
【0033】次に、第1表に示した実施例19の養毛料
について、上記養毛効果試験を行った。その結果を第3
表に表す。Next, the above hair growth effect test was conducted on the hair growth material of Example 19 shown in Table 1. The result is the third
Shown in the table.
【表5】 [Table 5]
【0034】第3表に示すように、実施例19の養毛料
を被験者に塗布することにより、抜毛の本数が減少し、
毛髪サイクルの休止期にある毛根の比率も減少すること
が明らかとなり、この本発明養毛料は優れた養毛効果を
有することが明らかになった。なお、第1表に示した他
の実施例の配合成分及び第2表に示した各実施例におけ
る発毛試験の結果を鑑みると、この実施例19の養毛料
に認められた優れた養毛効果は、他の実施例における養
毛料にも認められることは明らかである。As shown in Table 3, by applying the hair restorer of Example 19 to the subject, the number of hair removals decreased,
It was also found that the proportion of hair roots in the rest period of the hair cycle was also reduced, and it was revealed that the hair growth preparation of the present invention had an excellent hair growth effect. In view of the ingredients shown in Table 1 and the results of the hair growth test in each example shown in Table 2, the excellent hair growth observed in the hair growth preparation of Example 19 was considered. It is clear that the effect is also observed in the hair restoration in other examples.
【0035】以下、種々の処方の本発明養毛料の処方を
記載するが、各養毛料とも前記発毛試験及び養毛効果試
験において優れた発毛効果及び養毛作用を有していた。
なお、特に製法を記載しないこれらの養毛料は剤型に応
じた常法により製造した。Hereinafter, the formulations of the hair growth preparation of the present invention having various formulations are described. Each hair growth preparation had excellent hair growth and hair growth effects in the hair growth test and the hair growth effect test.
In addition, these hair nourishes which do not particularly describe the production method were produced by a conventional method according to the dosage form.
【0036】 〔実施例20〕 ヘアートニック 重量% シャクヤク(1,3−ブチレングリコール溶液) 0.01 N,N-シ゛ヒト゛ロキシメチル-2-テトラエイコシルアミンオキシト゛ 1.0 N,N-シ゛メチル-2-テ゛シルアミンオキシト゛ 1.0 ヒノキチオール 1.0 ビタミンB6 0.2 ビタミンEアセテート 0.02 メントール 0.2 センブリエキス 1.0 サリチル酸 0.1 マイカイカ抽出物(エタノール抽出液) 0.5 プロピレングリコール 2.0 ヒアルロン酸ナトリウム 0.01ホ゜リオキシエチレン (10モル)モノステアレート 2.0 75%エタノール 残 余Example 20 Hair Tonic Weight% Peony (1,3-butylene glycol solution) 0.01 N, N-diethyl peroxymethyl-2-tetraeicosylamine oxyt 1.0 N, N-dimethyl-2- Tesylamine oxytol 1.0 Hinokitiol 1.0 Vitamin B6 0.2 Vitamin E acetate 0.02 Menthol 0.2 Assembly extract 1.0 Salicylic acid 0.1 Maikamika extract (ethanol extract) 0.5 Propylene glycol 2.0 Sodium hyaluronate 0.01 polyoxyethylene (10 mol) monostearate 2.0 75% ethanol Residue
【0037】 〔実施例21〕 ヘアートニック 重量% ボタンピ抽出物(エタノール抽出液) 5.0 N,N-シ゛メチル-2-テ゛シルアミンオキシト゛ 0.05シ゛メチルオクチルホ゜リオキシエチレン (3モル)アミンオキシト゛ 0.05 ヒノキチオール 1.0 ビタミンB6 0.2 ビタミンEアセテート 0.02 メントール 0.2 サリチル酸 0.1 カッコン抽出物(エタノール抽出液) 0.5 プロピレングリコール 2.0 ヒアルロン酸ナトリウム 0.01ホ゜リオキシエチレン (10モル)モノステアレート 2.0 70%エタノール 残 余[Example 21] Hair tonic wt% buttonpi extract (ethanol extract) 5.0 N, N-dimethyl-2-decylamine oxyt 0.05 dimethyloctylpolyoxyethylene (3 mol) amine oxyt 05 Hinokitiol 1.0 Vitamin B6 0.2 Vitamin E acetate 0.02 Menthol 0.2 Salicylic acid 0.1 Bracken extract (ethanol extract) 0.5 Propylene glycol 2.0 Sodium hyaluronate 0.01 Polyoxyethylene ( 10 mol) monostearate 2.0 70% ethanol residue
【0038】 〔実施例22〕 ヘアートニック 重量% ボタンピ抽出物(1,3 −ブチレングリコール溶液) 2.5 シャクヤク抽出物(エタノール抽出液) 2.5 N,N-シ゛メチル-2-ト゛テ゛シルアミンオキシト゛ 2.5 N,N-シ゛メチル-2-テ゛シルテトラテ゛シルアミンオキシト゛ 2.5 N,N-シ゛ヒト゛ロキシメチル-2-ヘキサテ゛シルアミンオキシト゛ 2.5 N,N-シ゛ヒト゛ロキシメチル-2-エイコシルアミンオキシト゛ 2.5シ゛メチルヘキシルホ゜リオキシエチレン (5モル)アミンオキシト゛ 2.5シ゛メチルテトラテ゛シルホ゜リオキシエチレン (3モル)アミンオキシト゛ 2.5 N,N-シ゛メチル-2-テ゛シルアミンオキシト゛ 1.0 アルテア抽出物(エタノール抽出液) 0.05 プロピレングリコール 2.0 65%エタノール 残 余[Example 22] Hair tonic wt% buttonpi extract (1,3-butylene glycol solution) 2.5 Peony extract (ethanol extract) 2.5 N, N-dimethyl-2-todecylamine oxyto2 2.5 N, N-dimethyl-2-decyltetradecylamine oxyto 2.5 N, N-dimethylhydroxymethyl-2-hexadecylamine oxyto 2.5 N, N-dimethyl 2-hydroxymethyl-2-eicosylamine oxyto 2.5 Dimethylhexylpolyoxyethylene (5 mol) amine oxyto 2.5 dimethyltetradecylpolyoxyethylene (3 mol) amine oxy 2.5 N, N-dimethyl-2-decylamine oxyto 1.0 Altea extract (ethanol extract ) 0.05 Propylene glycol 2.0 65% ethanol Residue
【0039】 〔実施例23〕 ヘアートニック 重量% 95%エタノール 50.0ク゛リチルリチン 酸モノアンモニウム 0.05 ボタンピ抽出物(エタノール抽出液) 0.05 シャクヤク(1,3−ブチレングリコール溶液) 0.02 サフラン抽出物(エタノール抽出液) 0.02 ローズマリー抽出物(エタノール抽出液) 0.02 ペパーミント抽出物(エタノール抽出液) 0.02 トウキ抽出物(エタノール抽出液) 0.02 アルテア抽出物(エタノール抽出液) 0.02 ジオウ抽出物(エタノール抽出液) 0.02 ヨクイニン抽出物(エタノール抽出液) 0.02 ラウリル硫酸ナトリウム 0.1 N,N-シ゛メチル-2-テ゛シルテトラテ゛シルアミンオキシト゛ 0.5 N,N-シ゛ヒト゛ロキシメチル-2-ヘキサテ゛シルアミンオキシト゛ 0.5シ゛メチルヘキシルホ゜リオキシエチレン (5モル)アミンオキシト゛ 0.5 硬化ヒマシ 油エチレンオキシト゛(40モル)付加物 0.5 コハク酸 適 量 香料及び色素 適 量 精製水 残 余Example 23 Hair Tonic 95% by weight 95% Ethanol 50.0 Monoammonium glycyrrhizinate 0.05 Bompi extract (Ethanol extract) 0.05 Peony (1,3-butylene glycol solution) 0.02 Saffron Extract (ethanol extract) 0.02 Rosemary extract (ethanol extract) 0.02 Peppermint extract (ethanol extract) 0.02 Touki extract (ethanol extract) 0.02 Altea extract (ethanol extract) Liquid) 0.02 Diou extract (ethanol extract) 0.02 Yokuinin extract (ethanol extract) 0.02 Sodium lauryl sulfate 0.1 N, N-dimethyl-2-decyltetradecylamine oxyto 0.5 N , N-Dihydroxymethyl-2-hexadecylamineoxytoxin 0 5-di-methylhexyl Ho ° polyoxyethylene (5 moles) Amin'okishito Bu 0.5 hydrogenated castor oil ethyleneoxy preparative Bu (40 mol) adduct 0.5 Succinic acid q.s. perfume and dye qs Purified water Balance
【0040】 〔実施例24〕 O/W乳液型の養毛料 重量% (A相) N,N-シ゛メチル-2-ヘキシルアミンオキシト゛ 1.0 N,N-シ゛ヒト゛ロキシメチル-2-テ゛シルアミンオキシト゛ 2.5ホ゜リオキシエチレン (60モル) 付加硬化ヒマシ 油 2.0 グリセリン 10.0 ジプロピレングリコール 10.0 1,3−ブチレングリコール 4.0 シャクヤク抽出物(エタノール抽出液) 0.01 ボタンピ抽出物(エタノール抽出液) 0.2 ポリエチレングリコール1500 5.0 (B相) セチルイソオクタネート 10.0 スクワラン 5.0 ワセリン 2.0 プロピルパラベン 2.0 (C相) カルボキシビニルポリマー1%水溶液 30.0 ヘキサメタリン酸ソーダ 0.03 精製水 8.35 (D相) 精製水 4.5 (E相) KOH 0.12 精製水 残 余[Example 24] O / W emulsion type hair nourisher% by weight (A phase) N, N-dimethyl-2-hexylamine oxyt 1.0 N, N-diethyl humanoxymethyl-2-tesylamine oxyt 5 polyoxyethylene (60 mol) addition-hardened castor oil 2.0 glycerin 10.0 dipropylene glycol 10.0 1,3-butylene glycol 4.0 peony extract (ethanol extract) 0.01 buttonpipe extract (ethanol (Extract) 0.2 polyethylene glycol 1500 5.0 (phase B) cetyl isooctanoate 10.0 squalane 5.0 petrolatum 2.0 propylparaben 2.0 (phase C) carboxyvinyl polymer 1% aqueous solution 30.0 hexametaline Sodium acid 0.03 Purified water 8.35 (D phase) Purified water 4.5 (E phase) KOH 0.12 Purified water residue
【0041】<製法>A相及びB相をそれぞれ60℃で
加熱溶解し、混合してホモミキサー処理し、ゲルを調製
した。このゲルにD相を徐々に添加してホモミキサーで
分散させた。次に、このゲル分散物に予め溶解させたC
相を添加し、さらに予め溶解させたE相を添加してホモ
ミキサーで乳化して所望するO/W乳液型の養毛料を製
造した。<Preparation Method> The phases A and B were each dissolved by heating at 60 ° C., mixed, and treated with a homomixer to prepare a gel. Phase D was gradually added to the gel and dispersed with a homomixer. Next, C previously dissolved in this gel dispersion
The phase was added, and the previously dissolved phase E was added and emulsified with a homomixer to produce a desired O / W emulsion type hair restorer.
【0042】 〔実施例25〕 クリーム状養毛料 重量% (A相)シ゛メチルヘキシルホ゜リオキシエチレン (5 モル) アミンオキシト゛ 2.5 流動パラフィン 5.0 セトステアリルアルコール 5.5 グリセリルモノステアレート 3.0 EO(20モル)-2-オクチルト゛テ゛シルエーテル 3.0 プロピルパラベン 0.3 香料 0.1 (B相) ボタンピ抽出物(1,3−ブチレングリコール溶液) 0.03 シャクヤク抽出物(エタノール抽出液) 0.04 グリセリン 8.0 ジプロピレングリコール 20.0 ポリエチレングリコール4000 5.0 ヘキサメタリン酸ソーダ 0.005 精製水 残 余[Example 25] Cream hair restorer (% by weight) (A phase) dimethylhexylpolyoxyethylene (5 mol) amine oxyt 2.5 liquid paraffin 5.0 cetostearyl alcohol 5.5 glyceryl monostearate 3.0 EO (20 mol) -2-octyl decyl ether 3.0 propylparaben 0.3 Perfume 0.1 (Phase B) Peony extract (1,3-butylene glycol solution) 0.03 Peony extract (ethanol extract) 0.04 Glycerin 8.0 Dipropylene glycol 20.0 Polyethylene glycol 4000 5.0 Sodium hexametaphosphate 0.005 Purified water residue
【0043】<製法>A相及びB相をそれぞれ加熱溶解
して混合し、ホモミキサーで乳化して所望するクリーム
状養毛料を得た。<Production Method> The phases A and B were each dissolved by heating, mixed, and emulsified with a homomixer to obtain a desired creamy hair restorer.
【0044】 〔実施例26〕 エアゾール養毛料 重量% (原液処方) 95%エタノール 50.0 グリチルレチン酸 0.1 ボタンピ抽出物(エタノール抽出液) 0.025 シャクヤク抽出物(エタノール抽出液) 0.055 センブリエキス 0.1 ラウリル硫酸ナトリウム 0.1 N,N-シ゛メチル-2-テトラテ゛シルアミンオキシト゛ 0.2 N,N-シ゛ヒト゛ロキシメチル-2-テ゛シルアミンオキシト゛ 0.3シ゛メチルテ゛シルホ゜リオキシエチレン (5モル)アミンオキシト゛ 0.1 硬化ヒマシ 油エチレンオキシト゛(40モル)付加物 0.5 乳酸 適 量 乳酸ナトリウム 適 量 香料及び色素 適 量 精製水 残 余 (充填処方) 原液 50.0 液化石油ガス 50.0[Example 26] Aerosol hair restoration weight% (stock solution formulation) 95% ethanol 50.0 Glycyrrhetinic acid 0.1 Red pepper extract (ethanol extract) 0.025 Peony extract (ethanol extract) 0.055 Assembly extract 0.1 Sodium lauryl sulfate 0.1 N, N-Dimethyl-2-tetradecylamine oxyto 0.2 N, N-Dimethyl peroxymethyl-2-decylamine oxyto 0.3 Cimethylmethyl peroxypolyoxyethylene (5 mol) Amine oxyto 0.1 Hardened castor oil Ethylene oxyto (40 mol) adduct 0.5 Suitable for lactic acid Suitable for sodium lactate Suitable for fragrance and dye Suitable for purified water Residue (filling formula) Stock solution 50.0 Liquefied petroleum gas 50.0
【0045】<製法>原液処方を溶解させて原液を調製
し、これを缶に充填し、バルブ装着後、ガスを充填して
所望するエアゾール養毛料を調製した。<Preparation Method> A stock solution was prepared by dissolving the stock solution formulation, filled into a can, fitted with a valve, and then filled with gas to prepare a desired aerosol hair growth material.
【0046】[0046]
【発明の効果】本発明により、優れた脱毛防止効果や発
毛効果等の養毛効果を有する養毛料が提供される。Industrial Applicability According to the present invention, there is provided a hair restorer having a hair growth effect such as an excellent hair loss prevention effect and a hair growth effect.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 中沢 陽介 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内 (72)発明者 武田 俊祐 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内 (72)発明者 植村 雅明 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内 (72)発明者 田島 正裕 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第1リサーチセンター内 ──────────────────────────────────────────────────続 き Continued on the front page (72) Inventor Yosuke Nakazawa 1050 Nippa-cho, Kohoku-ku, Yokohama, Kanagawa Prefecture Inside Shiseido First Research Center Co., Ltd. (72) Inventor Shunsuke 1050 Nippacho, Kohoku-ku, Yokohama-shi, Kanagawa Inside Shiseido Daiichi Research Center Co., Ltd. (72) Inventor Masaaki Uemura 1050 Nippacho, Kohoku-ku, Yokohama, Kanagawa Prefecture Inside Shiseido Daiichi Research Center Co., Ltd. (72) Inventor Masahiro Tajima Niiwacho, Kohoku-ku, Yokohama, Kanagawa Prefecture 1050, Shiseido Daiichi Research Center Co., Ltd.
Claims (1)
種以上: 【化1】 (式中、R1 は炭素数が2〜24の直鎖の又は分枝鎖の
アルキル基、R2 は、メチル基又はヒドロキシエチル
基、Aはモノオキシエチレン基、nは0以上5以下の数
を表す)。1. A hair restorer comprising the following components: Peony extract and / or peanut extract One or two amine oxides represented by the following formula (I):
Species or more: (Wherein, R 1 is a linear or branched alkyl group having 2 to 24 carbon atoms, R 2 is a methyl group or a hydroxyethyl group, A is a monooxyethylene group, and n is 0 or more and 5 or less. Represents a number).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24117196A JP3639389B2 (en) | 1996-08-23 | 1996-08-23 | Hair nourishing |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24117196A JP3639389B2 (en) | 1996-08-23 | 1996-08-23 | Hair nourishing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH1067620A true JPH1067620A (en) | 1998-03-10 |
| JP3639389B2 JP3639389B2 (en) | 2005-04-20 |
Family
ID=17070308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP24117196A Expired - Fee Related JP3639389B2 (en) | 1996-08-23 | 1996-08-23 | Hair nourishing |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3639389B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015222248A (en) * | 2014-04-28 | 2015-12-10 | 株式会社ミルボン | Method for evaluating carbonylation level, method for screening component reducing carbonylation level and carbonylation level reduction agent |
-
1996
- 1996-08-23 JP JP24117196A patent/JP3639389B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015222248A (en) * | 2014-04-28 | 2015-12-10 | 株式会社ミルボン | Method for evaluating carbonylation level, method for screening component reducing carbonylation level and carbonylation level reduction agent |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3639389B2 (en) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3220761B2 (en) | Hair restoration | |
| JPH11269043A (en) | Cosmetic for scalp and hair | |
| JPH10279437A (en) | Hair cosmetic | |
| JPH1017439A (en) | Hair growing and restoring agent | |
| JP2001139436A (en) | Hair tonic and grower | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| JPH11302131A (en) | Cosmetic for scalp and hair | |
| JPH1067620A (en) | Hair grower | |
| JPH1067621A (en) | Hair grower | |
| JPH11255621A (en) | Cosmetic for scalp and hair | |
| JPH10273424A (en) | Cosmetic for hair | |
| JPH11246363A (en) | Hair restoration | |
| JPH0640858A (en) | Hair tonic | |
| JPH10273423A (en) | Cosmetic for hair | |
| JPH09328415A (en) | Hair tonic | |
| JP2002193753A (en) | Hair restorer | |
| JPH11302128A (en) | Cosmetic for scalp and hair | |
| JPH11322545A (en) | Cosmetic for scalp and hair | |
| JP2814090B2 (en) | Hair restoration | |
| JPH0352806A (en) | Hair-raising agent | |
| JP2000044436A (en) | Composition for scalp and hair treatment | |
| JPH11349452A (en) | Hair restorer | |
| JP2961528B2 (en) | Hair restoration | |
| JPH07277930A (en) | Hair growth material | |
| JPH10245393A (en) | Composition containing triterpenes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20031209 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040205 |
|
| A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040603 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041102 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041221 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050114 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080121 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 8 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |